HA-1A in septic patients with ARDS: Results from the pivotal trial
- 1 May 1994
- journal article
- clinical trial
- Published by Springer Nature in Intensive Care Medicine
- Vol. 20 (5) , 328-334
- https://doi.org/10.1007/bf01720904
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Critical Evaluation of New Agents for the Treatment of SepsisPublished by American Medical Association (AMA) ,1991
- A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative SepsisJAMA, 1991
- Effects of recombinant human tumor necrosis factor alpha, lymphotoxin, and Escherichia coli lipopolysaccharide on hemodynamics, lung microvascular permeability, and eicosanoid synthesis in anesthetized sheep.Circulation Research, 1989
- High-Dose Corticosteroids in Patients with the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1987
- Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapyAmerican Journal of Roentgenology, 1987
- APACHE IICritical Care Medicine, 1985
- PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPIDThe Lancet, 1985
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective studyJAMA, 1979
- ACUTE RESPIRATORY DISTRESS IN ADULTSThe Lancet, 1967